ES8101552A1 - Procedimiento para la produccion de esteres de fenoles sustituidos - Google Patents

Procedimiento para la produccion de esteres de fenoles sustituidos

Info

Publication number
ES8101552A1
ES8101552A1 ES488345A ES488345A ES8101552A1 ES 8101552 A1 ES8101552 A1 ES 8101552A1 ES 488345 A ES488345 A ES 488345A ES 488345 A ES488345 A ES 488345A ES 8101552 A1 ES8101552 A1 ES 8101552A1
Authority
ES
Spain
Prior art keywords
cycloalkyl
hydrogen
clofibric
acid esters
nicotinic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES488345A
Other languages
English (en)
Other versions
ES488345A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merz and Co GmbH and Co KG
Original Assignee
Merz and Co GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz and Co GmbH and Co KG filed Critical Merz and Co GmbH and Co KG
Publication of ES8101552A1 publication Critical patent/ES8101552A1/es
Publication of ES488345A0 publication Critical patent/ES488345A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE ESTERES DE FENOLES SUSTITUIDOS. CONSISTE EN HACER REACCIONAR 1 MOL DE UN HALURO ACIDO CON APROXIMADAMENTE 1 MOL DE UN FENOL EN PRESENCIA DE, AL MENOS, 1 MOL DE SUSTANCIA LIGADORA DE ACIDO, TAL COMO LA PIRIDINA. SE OBTIENE UN COMPUESTO DE FORMULA GENERAL (I). *FORMULA* SIENDO R: 3-PIRIDINILO, O 2-(4-CLOROFENOXI)-2-METILPROPILO; R'' ES HIDROGENO, C5-14 CICLOALQUILO (C5-14 CICLOALQUIL)-METILO, (C5-14 CICLOALQUIL)-CARBONILO, (C5-14 CICLOALQUIL)-ACETICO, 1-ADAMANTILO, 1-ADAMANTILMETILO, 1-ADAMANTILCARBONILO, 1-ADAMANTIL-ACETILO, CUMILO, P-CLOROBENZOILO, PIPORIDINO, O 2-PIRIMIDINILO, Y R ELEVADO A 2 ES HIDROGENO, -CH2)-4-; HALOGENO, C1-6 ALQUILO, CICLOALQUILO, METOXI, ETOXI, TRIFLUOROMETILO O NITRO. REDUCCION DE COMPONENTES LIPOIDES. 1
ES488345A 1979-02-08 1980-02-07 Procedimiento para la produccion de esteres de fenoles sustituidos Granted ES488345A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2904757 1979-02-08

Publications (2)

Publication Number Publication Date
ES8101552A1 true ES8101552A1 (es) 1980-12-16
ES488345A0 ES488345A0 (es) 1980-12-16

Family

ID=6062456

Family Applications (1)

Application Number Title Priority Date Filing Date
ES488345A Granted ES488345A0 (es) 1979-02-08 1980-02-07 Procedimiento para la produccion de esteres de fenoles sustituidos

Country Status (22)

Country Link
JP (1) JPS55129245A (es)
AR (1) AR228251A1 (es)
AT (1) AT374797B (es)
AU (1) AU532208B2 (es)
BE (1) BE881626A (es)
CA (1) CA1135689A (es)
CH (1) CH644092A5 (es)
DK (1) DK152360C (es)
ES (1) ES488345A0 (es)
FR (1) FR2448532A1 (es)
GB (1) GB2041937B (es)
GR (1) GR73905B (es)
HU (1) HU182099B (es)
IE (1) IE49385B1 (es)
IL (1) IL59337A (es)
IT (1) IT1141197B (es)
MX (1) MX6377E (es)
NL (1) NL8000826A (es)
PL (1) PL123379B1 (es)
SE (1) SE450381B (es)
SG (1) SG51185G (es)
YU (1) YU33880A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02502998A (ja) * 1988-01-22 1990-09-20 ハルコフスキ ナウチノ‐イススレドバテルスキ インスティテュト エンドクリノロギイ イ ヒミイ ゴルモノフ n‐クロロフェノキシイソ酪酸ウンデシルエステルおよびそれを基剤とした高類脂血症の治療用医薬製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3175M (fr) * 1963-06-25 1965-03-08 Analyses Et De Rech S Biolog M Nouveaux composés chimiques a action vaso-dilatatrice périphérique.
DE2352012A1 (de) * 1972-11-01 1974-05-09 Ciba Geigy Ag Neue aliphatisch substituierte arylchalkogeno-kohlenwasserstoffderivate und verfahren zu ihrer herstellung
ES438246A1 (es) * 1975-06-04 1977-01-16 Alter Sa Un procedimiento de preparacion del glicol 2-(p-clorofenoci)-2-metilpropinato nicotinato.
JPS57102866A (en) * 1980-12-19 1982-06-26 Kyorin Pharmaceut Co Ltd Nicotinic acid derivative and its preparation

Also Published As

Publication number Publication date
IT1141197B (it) 1986-10-01
PL123379B1 (en) 1982-10-30
CA1135689A (en) 1982-11-16
DK152360C (da) 1988-08-01
SG51185G (en) 1986-01-24
IE49385B1 (en) 1985-10-02
NL8000826A (nl) 1980-08-12
SE8000962L (sv) 1980-08-09
CH644092A5 (de) 1984-07-13
FR2448532B1 (es) 1984-12-14
IL59337A (en) 1984-10-31
MX6377E (es) 1985-05-23
HU182099B (en) 1983-12-28
DK152360B (da) 1988-02-22
AU5535580A (en) 1980-08-14
IE800236L (en) 1980-08-08
ATA70380A (de) 1983-10-15
IT8019782A0 (it) 1980-02-08
PL221888A1 (es) 1980-10-20
GR73905B (es) 1984-05-21
AU532208B2 (en) 1983-09-22
AR228251A1 (es) 1983-02-15
ES488345A0 (es) 1980-12-16
JPS55129245A (en) 1980-10-06
SE450381B (sv) 1987-06-22
YU33880A (en) 1983-06-30
GB2041937B (en) 1983-04-13
FR2448532A1 (fr) 1980-09-05
GB2041937A (en) 1980-09-17
AT374797B (de) 1984-05-25
DK53680A (da) 1980-08-09
BE881626A (fr) 1980-08-08
JPS6126993B2 (es) 1986-06-23

Similar Documents

Publication Publication Date Title
FI102175B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten piperatsiinijohdannaisten valmistamiseksi
NO308845B1 (no) Nye benzylpyrimidiner
HUT65868A (en) Process for producing ortosubstituted benzoyl-guanidine derivatives and pharmaceutical preparations containing them
GR3031492T3 (en) 1,4-Disubstituted piperazines for the treatment of disorders of the central nervous system and neuro-endocrine disorders
NO862621L (no) Fremgangsmaate ved fremstilling av pyridonkarboksylsyrederivater.
DK152090D0 (da) Piperidylsubstituerede indolderivater
DK26289A (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
ES512275A0 (es) "procedimiento para preparar espiro (piperidino-oxobenzoxazinas) substituidas en posicion 1 anti-hipertensivas".
PT76328A (en) Process for the preparation of pyridinocarboxylic acids esters having an anti-ischemic and anti-hypoxygenic effect and application thereof for the preparation of pharmaceutical compositions having an anti-ischemic and anti-hypoxygenic effect
AU563738B2 (en) Furan derivatives
NO913391L (no) Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider.
DE3856501D1 (de) Schlafverbesserungsmittel
YU182581A (en) Process for preparing new 5,10-dihydro-11h-dibenzo-(b,e)(1,4)diazepine-11-ones substituted in position 5
AU539568B2 (en) 2-(4-(diphenylmethylene)-1-piperidinyl)acetic acid derivatives
IE800236L (en) Esters.
NO955263L (no) N-substituerte azaheterosykliske karboksylsyrer og estere derav
HUT50464A (en) Process for producing phenothiazin derivatives
AU1390692A (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
NO955112L (no) Fremgangsmåte for fremstilling av oksazolidinkarboksylsyre samt anvendelse derav for fremstiling av terapeutisk aktive taxoider
HUT44471A (en) Process for production of derivatives of 8-/short carbon chained alkyl/-bicyclo /4,2,0/-octane, their salts and esthers and medical preparatives containing them as active substance
GR3015493T3 (en) Branched-chain alkyl esters of 2-(4-(2-piperidino ethoxy)benzoyl)benzoic acid, processes for their preparation and their use as spasmolytic agents.
RU2003105827A (ru) Средства против слабоумия, содержащие производные 2-арил-8-оксодигидропурина, в качестве активного ингредиента
ES8506620A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirrol-2-acetilaminoacido
ES8301933A1 (es) "procedimiento para la preparacion de derivados de 4-(5)-alcohil-mercaptoimidazoles".
ES8106144A1 (es) Procedimiento para la preparacion de derivados de aroilete- nilpiperidinobutirofenona

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519